US Stock MarketDetailed Quotes

TSHA Taysha Gene Therapies

Watchlist
  • 1.6900
  • -0.1800-9.63%
Close Oct 31 16:00 ET
  • 1.6900
  • 0.00000.00%
Post 19:54 ET
346.35MMarket Cap-3448P/E (TTM)

Taysha Gene Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Taysha Gene Therapies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.331M--
--2024/Q3-- / 1.649M--
Aug 12, 20242024/Q21.112M / 2.632M--
May 14, 20242024/Q13.411M / 2.305M--
Mar 19, 20242023/Q43.604M / 2.655M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.331M--
--2024/Q3-- / 1.649M--
Aug 12, 20242024/Q21.112M / 2.632M--
May 14, 20242024/Q13.411M / 2.305M--
Mar 19, 20242023/Q43.604M / 2.655M--

Unlock Free Earnings Estimates

Taysha Gene Therapies Earnings Reports

  • Taysha Gene Therapies | 10-Q: Q2 2024 Earnings Report

    Aug 12 08:36 ET

  • Taysha Gene Therapies | 10-Q: Q1 2024 Earnings Report

    May 14 16:24 ET

  • Taysha Gene Therapies | 10-K: FY2023 Annual Report

    Mar 19 16:18 ET

  • Taysha Gene Therapies | 10-Q: Q3 2023 Earnings Report

    Nov 14, 2023 16:17 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data